Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5194)
All Articles published online
|
Publishing Process of This Article
|
Oct 26, 2023 (publication date) through Oct 25, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Cases
ISSN
2307-8960
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| Lai SC, Loh EW, Chiou DI, Hong CT. Efficacy and safety of anti-vascular endothelial growth factor agents on corneal neovascularization: A meta-analysis. World J Clin Cases 2023; 11(30): 7337-7349 [PMID: 37969435 DOI: 10.12998/wjcc.v11.i30.7337] |
|
|
|
| ©2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA | |
| For: | Lai SC, Loh EW, Chiou DI, Hong CT. Efficacy and safety of anti-vascular endothelial growth factor agents on corneal neovascularization: A meta-analysis. World J Clin Cases 2023; 11(30): 7337-7349 [PMID: 37969435 DOI: 10.12998/wjcc.v11.i30.7337] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v11/i30/7337.htm |
| Number | Citing Articles |
| 1 |
Salvador García-Delpech, Sara Fathi Nieto, Ana Hervás Ontiveros, Patricia Udaondo, Damian Garcia-Teillard. Aganirsen as a Therapeutic Alternative for Modulating Corneal Neovascularization: A Real-World Case Series Study. Clinical Ophthalmology 2025; : 3497 doi: 10.2147/OPTH.S545516
|
| 2 |
Jingjuan Zhang, Yongjun Qi, Yongzheng Li, Furong Zhu, Yizhuo Geng, Yu Li, Bai Xue, Hongzheng Bi, Ya Jiao, Huan Min, Duyin Jiang, Guangjun Nie, Yingqiu Qi. PROTAC based targeted degradation of LRG1 for mitigating corneal neovascularization. Journal of Controlled Release 2025; 381: 113567 doi: 10.1016/j.jconrel.2025.02.063
|
| 3 |
Elsie Chan, Jennifer Fan Gaskin, Elsa C. Chan. Corneal Neovascularisation and Anti-VEGF Therapy. Targets 2025; 3(1): 9 doi: 10.3390/targets3010009
|
| 4 |
Muna Salim Al-Ruhaili, Haitham Hilal Al-Mahrouqi. Corneal melting following intrastromal injection of bevacizumab for corneal neovascularization. Oman Journal of Ophthalmology 2025; 18(2): 205 doi: 10.4103/ojo.ojo_344_24
|
| 5 |
Hakan Yildirim, Mehmet Balbaba, Mehmet Canleblebici, Ali Dal, Murat Erdağ, Nevin İlhan, Yesari Eröksüz, Canan Akdeniz Incili. Effect of Dasatinib on Oxidative Stress and Neovascularization in Experimental Corneal Neovascularization. Journal of Ocular Pharmacology and Therapeutics 2025; doi: 10.1177/10807683251370551
|
| 6 |
Yizhuo Geng, Jingjuan Zhang, Shiyu Song, Maoheng Xie, Hongzheng Bi, Huan Min, Jian Song, Yingqiu Qi. Inorganic nanomaterials as promising therapeutic agents for ocular neovascularization: Progress and perspectives. Materials Today Bio 2025; 33: 102051 doi: 10.1016/j.mtbio.2025.102051
|